Skip to Main Content
An official website of the United States government
Login Change: CDAS is now using the NIH Researcher Auth Service (RAS) to manage our existing login options. When logging into CDAS, you will be taken to RAS, where you can select your preferred login provider to access CDAS.

Browse Lab Results > 2005-0024

Trial Summary

About CDAS Project, PI, Publications: Insulin Resistance-Related Metabolic Markers and Pancreatic Cancer Risk

Datasets

Site: Pancreas

Inclusion Criteria:

  • No Prior History of Pancreatic Cancer
  • No Rare Cancers in Controls
  • T0 Serum Available
  • Not in Previous Biochem Study

Matching Factors:

  • Gender
  • Race
  • Age at Randomization (5 year intervals)
  • Year of Blood Draw
  • Month of Blood Draw (2 months)
  • Year of Birth (5 years)

Match Ratio: 2 to 1

Match Technique: Frequency matching only non-cases as controls.

Analytes:

  • Adiponectin
  • C-Peptide
  • Leptin
  • Transforming growth factor beta

Number of Cases: 120

Number of Controls: 120

Site: Pancreas

Inclusion Criteria:

  • No Prior History of Pancreatic Cancer
  • T0 Serum Available

Matching Factors:

  • Gender
  • Race
  • Age at Randomization (5 year intervals)
  • Year of Blood Draw
  • Month of Blood Draw (2 months)
  • Year of Birth (5 years)

Match Ratio: 2 to 1

Match Technique: Frequency matching with replacement and cases as controls (Incidence Density)

Analytes:

  • C-Peptide
  • C-Reactive Protein
  • Insulin-like Growth Factor 1
  • Insulin-like Growth Factor 2
  • Insulin-like Growth Factor Binding Protein 3
  • 25-Hydroxyvitamin D
  • Adiponectin
  • Cytotoxin-Associated Gene A
  • Helicobacter pylori
  • Leptin
  • Transforming Growth Factor Beta 1

Number of Cases: 187

Number of Controls: 382